id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-Q-1295-0026,FDA,FDA-2020-Q-1295,Withdrawal request for docket number FDA-2020-Q-1295,Other,Withdrawal,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,,2023-12-28T18:40:58Z,,0,0,0900006486364403
FDA-2020-Q-1295-0027,FDA,FDA-2020-Q-1295,FDA response to a withdrawal request for CA and Migraine Final,Other,Acknowledgement Letter/Receipt,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,,2023-12-28T18:41:04Z,,0,0,0900006486364405
FDA-2020-Q-1295-0021,FDA,FDA-2020-Q-1295,Reference 16 - Insulin and Ketone Responses to Ingestion of Medium and Long-chain Triglyercides in Man,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:58:09Z,,0,0,09000064844f9fd1
FDA-2020-Q-1295-0003,FDA,FDA-2020-Q-1295,Filing Letter signed,Other,Letter(s),2020-04-30T04:00:00Z,2020,4,2020-04-30T04:00:00Z,,2020-04-30T12:56:00Z,,0,0,09000064844fb10e
FDA-2020-Q-1295-0025,FDA,FDA-2020-Q-1295,Reference 20 - A new way to produce hyperketonemia - Use of ketone ester in a case of Alzheimer's Disease,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:58:35Z,,0,0,09000064844f9fd5
FDA-2020-Q-1295-0015,FDA,FDA-2020-Q-1295,Reference 10 - Treatment of Parkinson Disease with Diet Induced Hyperketonemia - A Feasibillity Study,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:57:23Z,,0,0,09000064844fb167
FDA-2020-Q-1295-0022,FDA,FDA-2020-Q-1295,Reference 17 - Hyperketonemia Induced in Man by Medium-Chain  Triglyceride,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:58:16Z,,0,0,09000064844f9fd2
FDA-2020-Q-1295-0014,FDA,FDA-2020-Q-1295,Reference 9 - Migraine improvement during short lasting ketogenesis - a proof-of-concept study,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:57:17Z,,0,0,09000064844fb166
FDA-2020-Q-1295-0018,FDA,FDA-2020-Q-1295,Reference 13 - Can Ketosis Help Migraine Sufferers A Case Study,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:57:47Z,,0,0,09000064844f9fce
FDA-2020-Q-1295-0024,FDA,FDA-2020-Q-1295,Reference 19 - Composition of Weight Lost during Short-Term  Weight Reduction,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:58:28Z,,0,0,09000064844f9fd4
FDA-2020-Q-1295-0007,FDA,FDA-2020-Q-1295,Reference 2  - Ketones - Metabolism's Ugly Duckling,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:56:30Z,,0,0,09000064844fb115
FDA-2020-Q-1295-0013,FDA,FDA-2020-Q-1295,Reference 8 - Ketone body therapy - from the ketogenic diet to the oral administration of ketone ester,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:57:10Z,,0,0,09000064844fb165
FDA-2020-Q-1295-0019,FDA,FDA-2020-Q-1295,Reference 14 - Diet transiently improves migraine in two twin sisters- possible role of Ketogenesis,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:57:54Z,,0,0,09000064844f9fcf
FDA-2020-Q-1295-0004,FDA,FDA-2020-Q-1295,Appendix B,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:56:10Z,,0,0,09000064844fb112
FDA-2020-Q-1295-0001,FDA,FDA-2020-Q-1295,QHC Petition for Caprylic and Capric Acid and Migraine,Other,Qualified Health Claims,2020-04-30T04:00:00Z,2020,4,2020-04-30T04:00:00Z,2020-06-30T03:59:59Z,2020-04-30T12:55:43Z,,0,0,09000064844fb10c
FDA-2020-Q-1295-0011,FDA,FDA-2020-Q-1295,Reference 6 - Potential Protective Mechanisms of Ketone Bodies in Migraine Prevention,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:56:58Z,,0,0,09000064844fb163
FDA-2020-Q-1295-0006,FDA,FDA-2020-Q-1295,Reference 1 - Studies Compare the Burdens of Chronic and Episodic Migraine,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:56:22Z,,0,0,09000064844fb114
FDA-2020-Q-1295-0023,FDA,FDA-2020-Q-1295,Reference 18 - Starvation-Induced Ketosis - Reduction in Dogs Enriched with Odd-Carbon Fatty Acids,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:58:22Z,,0,0,09000064844f9fd3
FDA-2020-Q-1295-0008,FDA,FDA-2020-Q-1295,Reference 3 - A study of oxidative stress in migraine with special reference to prophylactic therapy,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:56:36Z,,0,0,09000064844fb160
FDA-2020-Q-1295-0020,FDA,FDA-2020-Q-1295,Reference 15 Cortical functional correlates of responsiveness to short lasting preventive intrvention with,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:58:03Z,,0,0,09000064844f9fd0
FDA-2020-Q-1295-0010,FDA,FDA-2020-Q-1295,Reference 5 - The ketone metabolite hydroxybutyrate blocks NLRP3 Inflamatory Mediated Inflamatory Disease,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:56:49Z,,0,0,09000064844fb162
FDA-2020-Q-1295-0002,FDA,FDA-2020-Q-1295,Acknowledgment Letter,Other,Acknowledgement Letter/Receipt,2020-04-30T04:00:00Z,2020,4,2020-04-30T04:00:00Z,,2020-04-30T12:55:53Z,,0,0,09000064844fb10d
FDA-2020-Q-1295-0016,FDA,FDA-2020-Q-1295,"Reference 11 - Biomarkers, ketone bodies, and the prevention of Alzheimer's Disease",Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:57:30Z,,0,0,09000064844fb169
FDA-2020-Q-1295-0005,FDA,FDA-2020-Q-1295,Appendix C,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:56:16Z,,0,0,09000064844fb113
FDA-2020-Q-1295-0009,FDA,FDA-2020-Q-1295,Reference 4 - Modulation of oxidative stress and mitochondrial function by the ketogenic diet,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:56:43Z,,0,0,09000064844fb161
FDA-2020-Q-1295-0012,FDA,FDA-2020-Q-1295,Reference 7 - Ketogenic diet in migraine treatment-A Brief but Ancient History,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:57:03Z,,0,0,09000064844fb164
FDA-2020-Q-1295-0017,FDA,FDA-2020-Q-1295,Reference 12 - An Experience with a Ketogenic Dietary in Migraine,Supporting & Related Material,Background Material,2020-04-30T04:00:00Z,2020,4,,,2020-04-30T12:57:40Z,,0,0,09000064844f9fcd